Predictmedix AI Inc.
PMEDF
$0.0319
$0.009542.41%
| Weiss Ratings | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Rating | ||||
| Reward Index | Very Weak | |||
| Risk Index | Weak | |||
| Risk Grade | D | |||
| Reward Grade | E | |||
| Rating Factors | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Dividend Index | -- | |||
| Growth Index | Fair | |||
| Efficiency Index | Very Weak | |||
| Solvency Index | Fair | |||
| Total Return Index | Very Weak | |||
| Volatility Index | Weak | |||
| Beta / Standard Deviation | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Beta | 0.94 | |||
| Price History | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 7-Day Total Return | 6.33% | |||
| 30-Day Total Return | 279.76% | |||
| 60-Day Total Return | 314.29% | |||
| 90-Day Total Return | 120.00% | |||
| Year to Date Total Return | 198.13% | |||
| 1-Year Total Return | -4.20% | |||
| 2-Year Total Return | -63.38% | |||
| 3-Year Total Return | -65.10% | |||
| 5-Year Total Return | -63.75% | |||
| 52-Week High % Change | -16.49% | |||
| 52-Week Low % Change | 786.11% | |||
| Price | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| 52-Week High Price | $0.04 | |||
| 52-Week Low Price | $0.00 | |||
| 52-Week Low Price (Date) | Sep 09, 2024 | |||
| 52-Week High Price (Date) | Mar 15, 2024 | |||
| Valuation | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Market Cap | 4.61M | |||
| Enterprise Value | 5.20M | |||
| Price/Earnings (TTM) | -- | |||
| Earnings Per Share (TTM) | -0.01 | |||
| Earnings Per Share Growth | -60.56% | |||
| Price/Earnings To Growth | -- | |||
| Price/Sales (TTM) | -- | |||
| Price/Book (Q) | -7.25 | |||
| Enterprise Value/Revenue (TTM) | -- | |||
| Price | $0.03 | |||
| Enterprise Value/EBITDA (TTM) | -6.60 | |||
| Enterprise Value/EBIT | -6.41 | |||
| Market Cap Category | Nano Cap | |||
| Dividends and Shares | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Shares Outstanding | 150.26M | |||
| Dividend Yield | -- | |||
| Div. Per Share (Most Recent) | -- | |||
| Dividend Per Share (TTM) | -- | |||
| Payout Ratio (TTM) | -- | |||
| Dividend Per Share (Most Recent) | -- | |||
| Company Info | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Phone Number | 647 889 6916 | |||
| Address | 77 King Street West Toronto, ON M5K 1G8 | |||
| Website | www.Predictmedix.com | |||
| Country | Canada | |||
| Year Founded | -- | |||
| Profitability | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Operating Margin (TTM) | -- | |||
| Profit Margin | -- | |||
| Management Effectiveness | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Return on Assets | -149.72% | |||
| Return on Equity | -- | |||
| Income Statement | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Revenue (TTM) | -- | |||
| Total Revenue (TTM) | -- | |||
| Revenue Per Share | -- | |||
| Gross Profit (TTM) | -- | |||
| EBITDA (TTM) | -783.00K | |||
| EBIT (TTM) | -806.10K | |||
| Net Income (TTM) | -840.70K | |||
| Net Income Avl. to Common (TTM) | -840.70K | |||
| Total Revenue Growth (Q YOY) | -- | |||
| Earnings Growth (Q YOY) | 47.39% | |||
| EPS Diluted (TTM) | -0.01 | |||
| EPS Diluted Growth (Q YOY) | 45.45% | |||
| Balance Sheet | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash and Short-Term Inv. (Q) | -- | |||
| Cash Per Share (Q) | -- | |||
| Total Current Assets (Q) | 44.80K | |||
| Total Preferred Equity (Q) | -- | |||
| Total Equity (Q) | -655.70K | |||
| Current Ratio (Q) | 0.049 | |||
| Book Value Per Share (Q) | $0.00 | |||
| Total Assets (Q) | 257.20K | |||
| Total Current Liabilities (Q) | 912.90K | |||
| Total Debt (Q) | 0.00 | |||
| Total Liabilities (Q) | 912.90K | |||
| Total Common Equity (Q) | -655.70K | |||
| Cash Flow | PMEDF - OTC PK | Click to Compare |
Click to Compare |
Click to Compare |
| Cash from Investing (TTM) | -- | |||
| Cash from Financing (TTM) | 0.00 | |||
| Net Change in Cash (TTM) | -32.70K | |||
| Levered Free Cash Flow (TTM) | 304.50K | |||
| Cash from Operations (TTM) | -32.70K | |||
